347 related articles for article (PubMed ID: 33402095)
21. Characteristics and epidemiological profile of Buruli ulcer in the district of Tiassalé, south Côte d'Ivoire.
N'krumah RTAS; Koné B; Cissé G; Tanner M; Utzinger J; Pluschke G; Tiembré I
Acta Trop; 2017 Nov; 175():138-144. PubMed ID: 28034768
[TBL] [Abstract][Full Text] [Related]
22. Effectiveness of rifampicin-streptomycin for treatment of Buruli ulcer: a systematic review.
Tanywe A; Fernandez RS
JBI Database System Rev Implement Rep; 2017 Jan; 15(1):119-139. PubMed ID: 28085731
[TBL] [Abstract][Full Text] [Related]
23. Challenges Associated with Management of Buruli Ulcer/Human Immunodeficiency Virus Coinfection in a Treatment Center in Ghana: A Case Series Study.
Tuffour J; Owusu-Mireku E; Ruf MT; Aboagye S; Kpeli G; Akuoku V; Pereko J; Paintsil A; Bonney K; Ampofo W; Pluschke G; Yeboah-Manu D
Am J Trop Med Hyg; 2015 Aug; 93(2):216-23. PubMed ID: 26055745
[TBL] [Abstract][Full Text] [Related]
24. [Bifocal Buruli ulcer: multiple cephalic lesions after initiation of medical treatment].
Vagamon B; Ahogo KC; Aka BR; Diabaté A; Kouassi YI; Kourouma SH; Traoré C; Gue I; Yoboue P; Kanga JM; Taieb A
Ann Dermatol Venereol; 2013 Feb; 140(2):125-8. PubMed ID: 23395495
[TBL] [Abstract][Full Text] [Related]
25. Secondary Buruli ulcer skin lesions emerging several months after completion of chemotherapy: paradoxical reaction or evidence for immune protection?
Ruf MT; Chauty A; Adeye A; Ardant MF; Koussemou H; Johnson RC; Pluschke G
PLoS Negl Trop Dis; 2011 Aug; 5(8):e1252. PubMed ID: 21829740
[TBL] [Abstract][Full Text] [Related]
26. Challenges associated with the treatment of Buruli ulcer.
Aboagye SY; Kpeli G; Tuffour J; Yeboah-Manu D
J Leukoc Biol; 2019 Feb; 105(2):233-242. PubMed ID: 30168876
[TBL] [Abstract][Full Text] [Related]
27. Providing insight into the incubation period of Mycobacterium ulcerans disease: two case reports.
Amoako YA; Frimpong M; Awuah DO; Plange-Rhule G; Boakye-Yiadom E; Agbavor B; Sarpong F; Ahor H; Adu E; Danso KG; Abass MK; Asiedu K; Wansbrough-Jones M; Phillips RO
J Med Case Rep; 2019 Jul; 13(1):218. PubMed ID: 31315637
[TBL] [Abstract][Full Text] [Related]
28. Development of highly organized lymphoid structures in Buruli ulcer lesions after treatment with rifampicin and streptomycin.
Schütte D; Um-Boock A; Mensah-Quainoo E; Itin P; Schmid P; Pluschke G
PLoS Negl Trop Dis; 2007 Oct; 1(1):e2. PubMed ID: 17989779
[TBL] [Abstract][Full Text] [Related]
29. Comparison of 8 weeks standard treatment (rifampicin plus clarithromycin) vs. 4 weeks standard plus amoxicillin/clavulanate treatment [RC8 vs. RCA4] to shorten Buruli ulcer disease therapy (the BLMs4BU trial): study protocol for a randomized controlled multi-centre trial in Benin.
Johnson RC; Sáez-López E; Anagonou ES; Kpoton GG; Ayelo AG; Gnimavo RS; Mignanwande FZ; Houezo JG; Sopoh GE; Addo J; Orford L; Vlasakakis G; Biswas N; Calderon F; Della Pasqua O; Gine-March A; Herrador Z; Mendoza-Losana A; Díez G; Cruz I; Ramón-García S
Trials; 2022 Jul; 23(1):559. PubMed ID: 35804454
[TBL] [Abstract][Full Text] [Related]
30. Chronic wounds in Sierra Leone: Searching for Buruli ulcer, a NTD caused by Mycobacterium ulcerans, at Masanga Hospital.
Please HR; Vas Nunes JH; Patel R; Pluschke G; Tholley M; Ruf MT; Bolton W; Scott JA; Grobusch MP; Bolkan HA; Brown JM; Jayne DG
PLoS Negl Trop Dis; 2021 Oct; 15(10):e0009862. PubMed ID: 34644298
[TBL] [Abstract][Full Text] [Related]
31. Mycolactone diffuses into the peripheral blood of Buruli ulcer patients--implications for diagnosis and disease monitoring.
Sarfo FS; Le Chevalier F; Aka N; Phillips RO; Amoako Y; Boneca IG; Lenormand P; Dosso M; Wansbrough-Jones M; Veyron-Churlet R; Guenin-Macé L; Demangel C
PLoS Negl Trop Dis; 2011 Jul; 5(7):e1237. PubMed ID: 21811642
[TBL] [Abstract][Full Text] [Related]
32. Mycobacterium ulcerans disease in the middle belt of Ghana: An eight-year review from six endemic districts.
Adu EJ; Ampadu E
Int J Mycobacteriol; 2015 Jun; 4(2):138-42. PubMed ID: 26972882
[TBL] [Abstract][Full Text] [Related]
33. Buruli ulcer: Advances in understanding Mycobacterium ulcerans infection.
Walsh DS; Portaels F; Meyers WM
Dermatol Clin; 2011 Jan; 29(1):1-8. PubMed ID: 21095521
[TBL] [Abstract][Full Text] [Related]
34. Molecular Characterization of Mycolactone Producing Mycobacteria from Aquatic Environments in Buruli Ulcer Non-Endemic Areas in Côte d'Ivoire.
Tano MB; Dassi C; Mosi L; Koussémon M; Bonfoh B
Int J Environ Res Public Health; 2017 Feb; 14(2):. PubMed ID: 28208653
[TBL] [Abstract][Full Text] [Related]
35. Perceived water-related risk factors of Buruli ulcer in two villages of south-central Côte d'Ivoire.
Leuenberger A; Koné BV; N'krumah RTAS; Koffi DY; Bonfoh B; Utzinger J; Pluschke G
PLoS Negl Trop Dis; 2022 Dec; 16(12):e0010927. PubMed ID: 36516125
[TBL] [Abstract][Full Text] [Related]
36. Outcome of Streptomycin-Rifampicin treatment of Buruli Ulcer in two Ghanaian districts.
Iddrisah FN; Yeboah-Manu D; Nortey PA; Nyarko KM; Anim J; Antara SN; Kenu E; Wurapa F; Afari EA
Pan Afr Med J; 2016; 25(Suppl 1):13. PubMed ID: 28149438
[TBL] [Abstract][Full Text] [Related]
37. Assessing and managing wounds of Buruli ulcer patients at the primary and secondary health care levels in Ghana.
Addison NO; Pfau S; Koka E; Aboagye SY; Kpeli G; Pluschke G; Yeboah-Manu D; Junghanss T
PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005331. PubMed ID: 28245242
[TBL] [Abstract][Full Text] [Related]
38. Bacterial diversity in Buruli ulcer skin lesions: Challenges in the clinical microbiome analysis of a skin disease.
Van Leuvenhaege C; Vandelannoote K; Affolabi D; Portaels F; Sopoh G; de Jong BC; Eddyani M; Meehan CJ
PLoS One; 2017; 12(7):e0181994. PubMed ID: 28750103
[TBL] [Abstract][Full Text] [Related]
39. Disseminated
Hammoudi N; Dizoe AS; Regoui S; Davoust B; Drancourt M; Bouam A
Am J Trop Med Hyg; 2019 Sep; 101(3):491-493. PubMed ID: 31333157
[TBL] [Abstract][Full Text] [Related]
40. Integrated approach in the control and management of skin neglected tropical diseases in three health districts of Côte d'Ivoire.
Koffi AP; Yao TAK; Barogui YT; Diez G; Djakeaux S; Zahiri MH; Sopoh GE; Santos S; Asiedu KB; Johnson RC; Assé H
BMC Public Health; 2020 Apr; 20(1):517. PubMed ID: 32303204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
